Drug
Tralokinumab Tcs
Tralokinumab Tcs: highest development phase Phase 3, developed by LEO Pharma. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- LEO Pharma
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tralokinumab + TCS NCT06311682 | Phase 3 | Atopic Dermatitis |
Latest
No recent events.
Follow Tralokinumab Tcs on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.